{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:24:00Z","timestamp":1793424240132,"version":"4.5.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T00:00:00Z","timestamp":1318809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Spinal cord injury (SCI) results in profound bone loss due to muscle paralysis and the inability to ambulate. Sclerostin, a Wnt signaling pathway antagonist produced by osteocytes, is a potent inhibitor of bone formation. Short-term studies in rodent models have shown increased sclerostin in response to mechanical unloading that is reversed with reloading. These studies suggest that complete spinal cord injury, a condition resulting in mechanical unloading of the paralyzed lower extremities, will be associated with high sclerostin levels. We assessed the relationship between circulating sclerostin and bone density in 39 subjects with chronic SCI and 10 without SCI. We found that greater total limb bone mineral content was significantly associated with greater circulating levels of sclerostin. Sclerostin levels were reduced, not elevated, in subjects with SCI who use a wheelchair compared with those with SCI who walk regularly. Similarly, sclerostin levels were lower in subjects with SCI who use a wheelchair compared with persons without SCI who walk regularly. These findings suggest that circulating sclerostin is a biomarker of osteoporosis severity, not a mediator of ongoing bone loss, in long-term, chronic paraplegia. This is in contrast to the acute sclerostin-mediated bone loss shown in animal models of mechanical unloading in which high sclerostin levels suppress bone formation. Because these data indicate important differences in the relationship between mechanical unloading, sclerostin, and bone in chronic SCI compared with short-term rodent models, it is likely that sclerostin is not a good therapeutic target to treat chronic SCI-induced osteoporosis. \u00a9 2012 American Society for Bone and Mineral Research<\/jats:p>","DOI":"10.1002\/jbmr.546","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T12:04:28Z","timestamp":1318853068000},"page":"352-359","source":"Crossref","is-referenced-by-count":65,"title":["Association between sclerostin and bone density in chronic spinal cord injury"],"prefix":"10.1093","volume":"27","author":[{"given":"Leslie R","family":"Morse","sequence":"first","affiliation":[{"name":"Spinal Cord Injury Service, VA Boston Healthcare System, Boston, MA, USA"},{"name":"Department of Cytokine Biology, The Forsyth Institute, Cambridge, MA, USA"},{"name":"Spaulding-Harvard Spinal Cord Injury Model System, Spaulding Rehabilitation Hospital, Boston, MA, USA"},{"name":"Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supreetha","family":"Sudhakar","sequence":"additional","affiliation":[{"name":"Spaulding-Harvard Spinal Cord Injury Model System, Spaulding Rehabilitation Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery","family":"Danilack","sequence":"additional","affiliation":[{"name":"Programs in Research at VA Boston, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Tun","sequence":"additional","affiliation":[{"name":"Rehabilitation Medicine Service, VA Boston Healthcare System, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lazzari","sequence":"additional","affiliation":[{"name":"Primary Care Section, VA Boston Healthcare System and Boston University School of Medicine, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Gagnon","sequence":"additional","affiliation":[{"name":"VA Cooperative Studies Program, VA Boston Healthcare System, Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Garshick","sequence":"additional","affiliation":[{"name":"Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA"},{"name":"Pulmonary and Critical Care Medicine Section, Medical Service, VA Boston Healthcare System, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo A","family":"Battaglino","sequence":"additional","affiliation":[{"name":"Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, MA, USA"},{"name":"Department of Cytokine Biology, The Forsyth Institute, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,10,17]]},"reference":[{"key":"2024020318241063100_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-008-0671-6","article-title":"Osteoporotic fractures and hospitalization risk in chronic spinal cord injury","volume":"20","author":"Morse","year":"2009","journal-title":"Osteoporos Int."},{"key":"2024020318241063100_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.pmrj.2008.10.008","article-title":"VA-based survey of osteoporosis management in spinal cord injury","volume":"1","author":"Morse","year":"2009","journal-title":"PM R."},{"key":"2024020318241063100_bib3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.apmr.2008.12.004","article-title":"Dual energy x-ray absorptiometry of the distal femur may be more reliable than the proximal tibia in spinal cord injury","volume":"90","author":"Morse","year":"2009","journal-title":"Arch Phys Med Rehabil."},{"key":"2024020318241063100_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/PHM.0b013e31818a5f87","article-title":"Barriers to providing dual energy x-ray absorptiometry services to individuals with spinal cord injury","volume":"88","author":"Morse","year":"2009","journal-title":"Am J Phys Med Rehabil."},{"key":"2024020318241063100_bib5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J Bone Miner Res."},{"key":"2024020318241063100_bib6","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1359\/jbmr.090411","article-title":"Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt\/beta-catenin signaling","volume":"24","author":"Lin","year":"2009","journal-title":"J Bone Miner Res."},{"key":"2024020318241063100_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bone.2007.05.009","article-title":"Bone mass is inversely proportional to Dkk1 levels in mice","volume":"41","author":"MacDonald","year":"2007","journal-title":"Bone."},{"key":"2024020318241063100_bib8","first-page":"354","article-title":"Mechanical stimulation in vivo reduces osteocyte expression of sclerostin","volume":"6","author":"Robling","year":"2006","journal-title":"J Musculoskelet Neuronal Interact."},{"key":"2024020318241063100_bib9","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1074\/jbc.M705092200","article-title":"Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost\/sclerostin","volume":"283","author":"Robling","year":"2008","journal-title":"J Biol Chem."},{"key":"2024020318241063100_bib10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cmet.2007.05.001","article-title":"Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction","volume":"5","author":"Tatsumi","year":"2007","journal-title":"Cell Metab."},{"key":"2024020318241063100_bib11","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/jc.2009-2283","article-title":"Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women","volume":"95","author":"Mirza","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020318241063100_bib12","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1210\/jc.2010-0067","article-title":"Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss","volume":"95","author":"Gaudio","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020318241063100_bib13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/sj.sc.3101729","article-title":"A prospective assessment of mortality in chronic spinal cord injury","volume":"43","author":"Garshick","year":"2005","journal-title":"Spinal Cord."},{"key":"2024020318241063100_bib14","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.apmr.2005.02.006","article-title":"Dyspnea during daily activities in chronic spinal cord injury","volume":"86","author":"Grandas","year":"2005","journal-title":"Arch Phys Med Rehabil."},{"key":"2024020318241063100_bib15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00002060-200207000-00006","article-title":"Comparison of the revised 2000 American Spinal Injury Association classification standards with the 1996 guidelines","volume":"81","author":"Kirshblum","year":"2002","journal-title":"Am J Phys Med Rehabil."},{"key":"2024020318241063100_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","article-title":"Relation of age, gender, and bone mass to circulating sclerostin levels in women and men","volume":"26","author":"Modder","year":"2011","journal-title":"J Bone Miner Res."},{"key":"2024020318241063100_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1047-9651(18)30150-5","article-title":"Metabolic changes in persons after spinal cord injury","volume":"11","author":"Bauman","year":"2000","journal-title":"Phys Med Rehabil Clin N Am."},{"key":"2024020318241063100_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S8756-3282(00)00326-4","article-title":"Supralesional and sublesional bone mineral density in spinal cord-injured patients","volume":"27","author":"Dauty","year":"2000","journal-title":"Bone."},{"key":"2024020318241063100_bib19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.sc.3100704","article-title":"Osteoporosis after spinal cord injury","volume":"36","author":"Demirel","year":"1998","journal-title":"Spinal Cord."},{"key":"2024020318241063100_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/sj.sc.3100905","article-title":"Bone mineral density in upper and lower extremities during 12 months after spinal cord injury measured by peripheral quantitative computed tomography","volume":"38","author":"Frey-Rindova","year":"2000","journal-title":"Spinal Cord."},{"key":"2024020318241063100_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jor.1100100309","article-title":"Osteoporosis after spinal cord injury","volume":"10","author":"Garland","year":"1992","journal-title":"J Orthop Res."},{"key":"2024020318241063100_bib22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00198-007-0494-x","article-title":"Spinal cord injury causes rapid osteoclastic resorption and growth plate abnormalities in growing rats (SCI-induced bone loss in growing rats)","volume":"19","author":"Morse","year":"2008","journal-title":"Osteoporos Int."},{"key":"2024020318241063100_bib23","doi-asserted-by":"crossref","first-page":"24113","DOI":"10.1074\/jbc.M301716200","article-title":"Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity","volume":"278","author":"Kusu","year":"2003","journal-title":"J Biol Chem."},{"key":"2024020318241063100_bib24","doi-asserted-by":"crossref","first-page":"20764","DOI":"10.1073\/pnas.0805133106","article-title":"Regulation of bone formation by osteoclasts involves Wnt\/BMP signaling and the chemokine sphingosine-1-phosphate","volume":"105","author":"Pederson","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2024020318241063100_bib25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet."},{"key":"2024020318241063100_bib26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.10401","article-title":"A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population","volume":"110","author":"Staehling-Hampton","year":"2002","journal-title":"Am J Med Genet."},{"key":"2024020318241063100_bib27","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem."},{"key":"2024020318241063100_bib28","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature756","article-title":"Kremen proteins are Dickkopf receptors that regulate Wnt\/beta-catenin signalling","volume":"417","author":"Mao","year":"2002","journal-title":"Nature."},{"key":"2024020318241063100_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1517\/14712598.2011.540565","article-title":"Sclerostin monoclonal antibody therapy with AMG 785: a potential treatment for osteoporosis","volume":"11","author":"Lewiecki","year":"2011","journal-title":"Expert Opin Biol Ther."},{"issue":"Suppl 1","key":"2024020318241063100_bib30","doi-asserted-by":"crossref","first-page":"i119","DOI":"10.1136\/ard.2010.141150","article-title":"Targeting sclerostin as potential treatment of osteoporosis","volume":"70","author":"Papapoulos","year":"2011","journal-title":"Ann Rheum Dis."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.546","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/27\/2\/352\/56562198\/546_ftp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/27\/2\/352\/56562198\/546_ftp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T10:48:22Z","timestamp":1710326902000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/27\/2\/352-359\/7598511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,17]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,10,17]]},"published-print":{"date-parts":[[2012,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.546","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,2,1]]},"published":{"date-parts":[[2011,10,17]]}}}